Schedule 13G ownership disclosure

BIOMX INC

Common Stock, $0.0001 par value per share · CUSIP: 09090D103

Event date: 2024-09-30

Filing-level shares
4,094,558
Percent of class
19.99%
  • Cystic Fibrosis Foundation

    Shares: 4,094,558 · Class: 19.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021160
Form type
SCHEDULE 13G/A
Filer
BiomX Inc.
CIK
CIK 1739174
Filed
Feb 14, 2025
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub